Michelle Grove, CNM | |
910 Liberty Bell Dr, Amherst, OH 44001-1234 | |
(440) 989-5111 | |
(440) 989-5123 |
Full Name | Michelle Grove |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 910 Liberty Bell Dr, Amherst, Ohio |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164484671 | NPI | - | NPPES |
0224108 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | COANM01690 (Ohio) | Primary |
Entity Name | University Primary Care Practices Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
"Training" of precursors of white blood cells leads to a sustained positive response of the hematopoietic system. This effect could help accelerate the formation of new white blood cells, which are vitally needed during chemotherapy, a process that can slow down hematopoiesis.
RESEARCHERS from the University of Salford have used new techniques to show that people with artificial arms and hands are doing damage to their intact limbs.
With an ever ageing population and more people surviving a heart attack, heart failure is now the world's most prevalent chronic cardiovascular disease.
Four novel biomarkers have been identified which may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease, according to a study conducted by researchers in Australia, who determined the biomarkers may be used in different combinations to successfully identify patients with either of the airway diseases.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.
› Verified 8 days ago
Entity Name | University Hospitals Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
"Training" of precursors of white blood cells leads to a sustained positive response of the hematopoietic system. This effect could help accelerate the formation of new white blood cells, which are vitally needed during chemotherapy, a process that can slow down hematopoiesis.
RESEARCHERS from the University of Salford have used new techniques to show that people with artificial arms and hands are doing damage to their intact limbs.
With an ever ageing population and more people surviving a heart attack, heart failure is now the world's most prevalent chronic cardiovascular disease.
Four novel biomarkers have been identified which may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease, according to a study conducted by researchers in Australia, who determined the biomarkers may be used in different combinations to successfully identify patients with either of the airway diseases.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michelle Grove, CNM 910 Liberty Bell Dr, Amherst, OH 44001-1234 Ph: (440) 989-5111 | Michelle Grove, CNM 910 Liberty Bell Dr, Amherst, OH 44001-1234 Ph: (440) 989-5111 |
News Archive
"Training" of precursors of white blood cells leads to a sustained positive response of the hematopoietic system. This effect could help accelerate the formation of new white blood cells, which are vitally needed during chemotherapy, a process that can slow down hematopoiesis.
RESEARCHERS from the University of Salford have used new techniques to show that people with artificial arms and hands are doing damage to their intact limbs.
With an ever ageing population and more people surviving a heart attack, heart failure is now the world's most prevalent chronic cardiovascular disease.
Four novel biomarkers have been identified which may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease, according to a study conducted by researchers in Australia, who determined the biomarkers may be used in different combinations to successfully identify patients with either of the airway diseases.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.
› Verified 8 days ago
Patricia J Lupe, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 910 Liberty Bell Dr, Amherst, OH 44001 Phone: 440-989-5111 Fax: 440-989-5123 | |
Laurie Galvan, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 910 Liberty Bell Dr, Amherst, OH 44001 Phone: 440-989-5111 Fax: 440-989-5123 | |
Aimee Holmes, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 910 Liberty Bell Dr, Amherst, OH 44001 Phone: 440-989-5111 Fax: 440-989-5123 | |
Darla Mitchell, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 910 Liberty Bell Dr, Amherst, OH 44001 Phone: 440-989-5111 | |
Ms. Heather Ann Bruderer, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 578 N Leavitt Rd, Amherst, OH 44001 Phone: 440-960-3912 Fax: 440-960-3913 |